CytoMed Therapeutics
GDTC
#8287
Rank
$23.42 M
Marketcap
$2.03
Share price
-3.33%
Change (1 day)
-53.23%
Change (1 year)

EPS for CytoMed Therapeutics (GDTC)

EPS in 2021: -$0.14

According to CytoMed Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.14. In 2021 the company made an earnings per share (EPS) of -$0.14 a decrease over its 2020 EPS that were of -$0.13.

EPS history for CytoMed Therapeutics from 2020 to 2021

Annual EPS

Year EPS Change
2021-$0.143.73%
2020-$0.13